Do NPM1 and FLT3-ITD mutations modify prognosis in patients treated with non-intensive regimens? – ANNALS OF HEMATOLOGY

Suárez, EU; Boluda, B; Lavilla, E; Tormo, M; Botella, C; Gil, C; Vives, S; Rodríguez, C; Serrano, J; Sayas, MJ; Martínez-Sánchez, P; Ramos, F; Bernal, T; Algarra, L; Bergua-Burgues, JM; Pérez-Simón, JA; Herrera, P; Barrios, M; Noriega-Concepción, V; Raposo-Puglia, JA; Ayala, R; Barragán, E; Martínez-Cuadrón, D; Amigo, ML; López-Lorenzo, JL; Lázaro-García, A; Guimaraes, JE; Colorado, M; García-Boyero, R; De Rueda-Ciller, B; Foncillas-García, M; Hong, A; Labrador, J; Alonso-Dominguez, JM; Montesinos, P – 2024 – 10.1007/s00277-024-05840-7